Breast cancer remains a leading cause of cancer-related mortality in women, reflecting
profound disease heterogeneity, metastasis, and therapeutic resistance. Over the last …

Breast cancer, like other cancers, is a genetic disease. The disease is caused by acquired
molecular alterations during the lifetime of an individual and by inherited mutant genes. Risk …

Breast cancer is not a single disease, but rather is composed of distinct subtypes associated
with different clinical outcomes. Understanding this heterogeneity is key for the development …

Despite the wide improvements in breast cancer (BC) detection and adjuvant treatment, BC
is still responsible for approximately 40,000 deaths annually in the United States. Novel …

As the most frequent and vulnerable malignancy among women, breast cancer universally
manifests a formidable healthcare challenge. From a biological and molecular perspective, it …

Breast cancer is a heterogeneous disease. There is a high degree of diversity between and
within tumors as well as among cancer-bearing individuals, and all of these factors together …

Despite the remarkable enhancements in breast cancer classification and characterization,
an exhaustive comprehension of the underlying carcinogenic processes and an accurate …

Increased understanding of the molecular heterogeneity that is intrinsic to the various
subtypes of breast cancer will likely shape the future of breast cancer diagnosis, prognosis …

Breast cancer is a heterogeneous disease, and stratification of tumors is paramount to
achieve better clinical outcomes. While it is common to stratify and treat breast tumors as a …

Breast cancer is noted for disparate clinical behaviors and patient outcomes, despite
common histopathological features at diagnosis. Molecular pathogenesis studies suggest …